Alessandro Gambella
ally-ikz.bsky.social
Alessandro Gambella
@ally-ikz.bsky.social
Enthusiastic pathologist | PhD candidate | Cholangiocarcinima Foundation Fellow | Liver Fellow Network Content Writer | ESP_Pathology Alumni | CAP International Fellow | 🇮🇹🇺🇲
Reposted by Alessandro Gambella
The greatest review written on liver biopsy: indications, interpretation, and its future

By Dr Purva Gopal and colleagues in HepCommJournal

Open access journals.lww.com/hepcomm/full...

#liversky #pathsky
January 9, 2025 at 12:46 AM
Reposted by Alessandro Gambella
Approaches for profiling the spatial proteome in tissues are the basis of atlas-scale projects that are delivering on their promise for understanding biological complexity in health and disease. Nature Methods names spatial proteomics its Method of the Year. 🧪
Method of the Year 2024: spatial proteomics - Nature Methods
Approaches for profiling the spatial proteome in tissues are the basis of atlas-scale projects that are delivering on their promise for understanding biological complexity in health and disease.
go.nature.com
December 12, 2024 at 4:23 PM
Reposted by Alessandro Gambella
Happy to see more and more of my #livertwitter friends making the transition to #liversky! Let’s try to rebuild/improve upon the wonderful education/information sharing community here!
December 3, 2024 at 11:45 PM
Reposted by Alessandro Gambella
Transplant Atlantic: Dr Zuhaib Mir on innovation
🛩In NS, travel for procurement is typical and far.
🫤Problems: cost, volume assoc with outcomes, time, delays (traffic, weather), enviro impact (ex. Halifax to Moncton round trip 1.1 metric carbon tonnes)
#liversky
pubmed.ncbi.nlm.nih.gov/36088644/
The carbon footprint of organ acquisition in the United States - PubMed
The carbon footprint of organ acquisition in the United States
pubmed.ncbi.nlm.nih.gov
November 15, 2024 at 4:04 PM
Reposted by Alessandro Gambella
Primary biliary cholangitis

- predominantly females, 40-70yo
- triggers: smoking, xenobiotics
- histology: non-suppurative destructive cholangitis, florid duct lesion
- treatment: UDCA, OCA, ?PPAR agonists

#LiverSky #MedSky
November 17, 2024 at 1:41 AM
Reposted by Alessandro Gambella
🔬EPeP is a free resource w/ interactive cases that make learning fun and easy. Dive into real-life scenarios, get instant feedback + print a certificate when you’re done.

It’s all FREE!

🔗 pathology.emory.edu/epep

#PathSky #Pathology #PathResidents #MedSky #Path2Path #PathMatch25 #PathMatch2025
November 21, 2024 at 8:31 PM
Reposted by Alessandro Gambella
We are on our second starter pack for GI / Hepatology
Part 1: go.bsky.app/8Pho2tp
Part 2: go.bsky.app/VGyLKjR

#medsky #GIsky #LiverSky
November 15, 2024 at 3:17 PM
Reposted by Alessandro Gambella
ALD and MASLD are a lot alike. How do we tell them apart on pathology?

Cindy Behling walks us through in this fantastic talk. 👏

#TLM24 #Liversky @juanpabloarab.bsky.social
#pathologysky
November 16, 2024 at 4:45 PM
Reposted by Alessandro Gambella
Best of liver fellow network
@blaneymd.bsky.social #TLM24
November 16, 2024 at 7:05 PM
Reposted by Alessandro Gambella
🔥🔥🔥 The Best of Liver Fellow Network Session at the Liver Meeting! The future of #liversky is bright! 🌟🌟🌟 @blaneymd.bsky.social
November 16, 2024 at 7:26 PM